107 related articles for article (PubMed ID: 22362873)
1. Life expectancy in hereditary cancer predisposing diseases: an observational study.
Wilding A; Ingham SL; Lalloo F; Clancy T; Huson SM; Moran A; Evans DG
J Med Genet; 2012 Apr; 49(4):264-9. PubMed ID: 22362873
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
3. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.
Evans DG; Howard E; Giblin C; Clancy T; Spencer H; Huson SM; Lalloo F
Am J Med Genet A; 2010 Feb; 152A(2):327-32. PubMed ID: 20082463
[TBL] [Abstract][Full Text] [Related]
4. Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent years.
Ingham S; Huson SM; Moran A; Wylie J; Leahy M; Evans DG
Eur J Cancer; 2011 Dec; 47(18):2723-8. PubMed ID: 21700447
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
6. The global impact of noncommunicable diseases: estimates and projections.
Manton KG
World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
[TBL] [Abstract][Full Text] [Related]
7. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?
Kehrer-Sawatzki H; Cooper DN
J Med Genet; 2008 Oct; 45(10):622-31. PubMed ID: 18511569
[TBL] [Abstract][Full Text] [Related]
8. Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: a nationwide retrospective cohort study.
van Heumen BW; Nieuwenhuis MH; van Goor H; Mathus-Vliegen LE; Dekker E; Gouma DJ; Dees J; van Eijck CH; Vasen HF; Nagengast FM
Surgery; 2012 May; 151(5):681-90. PubMed ID: 22265391
[TBL] [Abstract][Full Text] [Related]
9. The effect of revised populations on mortality statistics for the United States, 2000.
Anderson RN; Arias E
Natl Vital Stat Rep; 2003 Jun; 51(9):1-24. PubMed ID: 12795490
[TBL] [Abstract][Full Text] [Related]
10. Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989.
Evans DG; O'Hara C; Wilding A; Ingham SL; Howard E; Dawson J; Moran A; Scott-Kitching V; Holt F; Huson SM
Eur J Hum Genet; 2011 Nov; 19(11):1187-91. PubMed ID: 21694737
[TBL] [Abstract][Full Text] [Related]
11. [Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].
Soulié M; Villers A; Richaud P; Prapotnich D; Ruffion A; Grosclaude P
Prog Urol; 2001 Dec; 11(6):1195-204. PubMed ID: 11859652
[TBL] [Abstract][Full Text] [Related]
12. Malignant peripheral nerve sheath tumours in inherited disease.
Evans DG; Huson SM; Birch JM
Clin Sarcoma Res; 2012 Oct; 2(1):17. PubMed ID: 23036231
[TBL] [Abstract][Full Text] [Related]
13. The NSW & ACT Hereditary Cancer Registers.
Weir L; Spigelman A; Scott R; Kirk J; Zeckendorf S; Sitas F
Aust Fam Physician; 2005; 34(1-2):53-8. PubMed ID: 15727359
[TBL] [Abstract][Full Text] [Related]
14. Measuring the impact of HIV/AIDS, heart disease and malignant neoplasms on life expectancy in the USA from 1987 to 2000.
Lai DJ; Tarwater PM; Hardy RJ
Public Health; 2006 Jun; 120(6):486-92. PubMed ID: 16730037
[TBL] [Abstract][Full Text] [Related]
15. Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors.
Evans DG; Ingham SL
Appl Clin Genet; 2013; 6():53-61. PubMed ID: 23935382
[TBL] [Abstract][Full Text] [Related]
16. The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis.
Mallinson EK; Newton KF; Bowen J; Lalloo F; Clancy T; Hill J; Evans DG
Gut; 2010 Oct; 59(10):1378-82. PubMed ID: 20660077
[TBL] [Abstract][Full Text] [Related]
17. Overall mortality, incremental life expectancy, and cause of death at 25 years in the program on the surgical control of the hyperlipidemias.
Buchwald H; Rudser KD; Williams SE; Michalek VN; Vagasky J; Connett JE
Ann Surg; 2010 Jun; 251(6):1034-40. PubMed ID: 20485136
[TBL] [Abstract][Full Text] [Related]
18. Sex differentials in life expectancy and mortality in developed countries: an analysis by age groups and causes of death from recent and historical data.
United Nations. Department of International Economic and Social Affairs. Population Division
Popul Bull UN; 1988; 25():65-107. PubMed ID: 12315555
[TBL] [Abstract][Full Text] [Related]
19. Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation.
Eckardt VF; Hoischen T; Bernhard G
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):956-60. PubMed ID: 18787460
[TBL] [Abstract][Full Text] [Related]
20. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
Engholm G; Gislum M; Bray F; Hakulinen T
Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
